Finance

Beta
Lists
PDSB:NASDAQ
PDS Biotechnology Corp
၀.၈၂ US$
-၁.၂၂%
(-၀.၀၁၀) 1D
၀.၈၄ US$
+၁.၉၉% (+၀.၀၁၆)
After hours
Closed: ဇူ ၈, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PDSB...
Open
၀.၈၃ US$
High
၀.၈၅ US$
Low
၀.၈၀ US$
Mkt. cap
၄.၅၈ ကုဋေ
Avg. vol.
၇.၈၃ သိန်း
Volume
၀.၀၀
52-wk high
၁.၅၅ US$
52-wk low
၀.၅၁ US$
EPS
-၀.၆၈ US$
Beta
၁.၅၉
Shares outstanding
၅.၅၈ ကုဋေ
No. of employees
၂၁
Open
၀.၈၃ US$
High
၀.၈၅ US$
Low
၀.၈၀ US$
Mkt. cap
၄.၅၈ ကုဋေ
Avg. vol.
၇.၈၃ သိန်း
Volume
၀.၀၀
52-wk high
၁.၅၅ US$
52-wk low
၀.၅၁ US$
EPS
-၀.၆၈ US$
Beta
၁.၅၉
Shares outstanding
၅.၅၈ ကုဋေ
No. of employees
၂၁
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
US Stock Market Today: S&P 500 Futures Fall On Higher Yields And Inflation Jitters
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
Zillow Group, Inc. (NASDAQ:Z) Given Consensus Rating of "Moderate Buy" by Analysts
Investor's Business Daily
Investor's Business Daily
·
ပြီးခဲ့သည့် ၃ နာရီ
Futures, Oil Prices Rise; 5 Stocks To Watch
About PDS Biotechnology Corp
CEO-
Employees၂၁
Founded၂၀၀၅
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to PDSB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for PDSB in the last 3 months
Highest
Current ၀.၈၂ US$
၁၅.၀၀ US$ (+၁,၇၁၈.၄၀%)
Average
၁၅.၀၀ US$ (+၁,၇၁၈.၄၀%)
Lowest
၁၅.၀၀ US$ (+၁,၇၁၈.၄၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
၁၅.၀၀ US$
+၁,၇၁၈.၄%
05/14/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
၃.၀၀ US$
+၂၆၃.၇%
04/07/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
၄.၅၀ US$
+၄၄၅.၅%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၄.၂၁ သန်း
၄.၅၈ သန်း
၄.၄၁ သန်း
၃.၄၆ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၄၁ သန်း
၃.၅၆ သန်း
၂.၂၇ သန်း
၃.၀၆ သန်း
Operating expense
၇.၆၂ သန်း
၈.၁၄ သန်း
၆.၆၇ သန်း
၆.၅၂ သန်း
Total operating expenses
၇.၆၂ သန်း
၈.၁၄ သန်း
၆.၆၇ သန်း
၆.၅၂ သန်း
Operating income
-၇.၆၂ သန်း
-၈.၁၄ သန်း
-၆.၆၇ သန်း
-၆.၅၂ သန်း
Other non operating income
-
-
-
-
EBT including unusual items
-၉.၄၃ သန်း
-၉.၀၁ သန်း
-၇.၅၆ သန်း
-၇.၃၅ သန်း
EBT excluding unusual items
-၉.၄၃ သန်း
-၉.၀၁ သန်း
-၇.၅၆ သန်း
-၇.၃၅ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၉.၄၃ သန်း
-၉.၀၁ သန်း
-၇.၅၆ သန်း
-၇.၃၅ သန်း
Net profit margin
-
-
-
-
Earnings per share
-၀.၂၁
-၀.၁၉
-၀.၁၄
-၀.၁၃
Interest and investment income
၃.၃၄ သိန်း
၂.၈၁ သိန်း
၂.၂၅ သိန်း
၁.၈၇ သိန်း
Interest expense
-၂.၁၄ သန်း
-၁.၁၅ သန်း
-၁.၁၁ သန်း
-၁.၀၁ သန်း
Net interest expenses
-၁.၈၁ သန်း
-၈.၆၉ သိန်း
-၈.၈၈ သိန်း
-၈.၂၈ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၇.၆၁ သန်း
-၈.၁၃ သန်း
-၆.၆၆ သန်း
-၆.၅၁ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more